A Design-Conversed Strategy Establishes the Performance Safe Space for Doxorubicin Nanosimilars.
Nagpal S, Png Yi Jie J, Malinovskaya J, Kovshova T, Jain P, Naik S, Khopade A, Bhowmick S, Shahi P, Chakra A, Bhokari A, Shah V, Gelperina S, Wacker MG.
Nagpal S, et al. Among authors: gelperina s.
ACS Nano. 2024 Feb 27;18(8):6162-6175. doi: 10.1021/acsnano.3c08290. Epub 2024 Feb 15.
ACS Nano. 2024.
PMID: 38359902
Free PMC article.